Blog

Frequency Therapeutics, Astellas sign deal to tune of $625M

lucchino-headshot900xx533-800-0-0

Japanese firm Astellas Health will join Woburn’s Frequency Therapeutics as it steers its first treatment for the most common cause of hearing loss through the clinic.

Read More